QT
EBS icon

Quantamental Technologies’s Emergent Biosolutions EBS Stock Holding History

Quantamental Technologies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,291
Closed -$226K – 545
2022
Q2 		$226K Sell
7,291
-405
-5% -$13.8K 0.1% 324
2022
Q1 		$316K Buy
+7,696
New +$339K 0.18% 224
2020
Q4 		– Sell
-2,699
Closed -$279K – 149
2020
Q3 		$279K Buy
+2,699
New +$291K 0.21% 165
2019
Q4 		– Sell
-1,474
Closed -$77K – 673
2019
Q3 		$77K Buy
1,474
+950
+181% +$44.3K 0.03% 828
2019
Q2 		$25K Sell
524
-475
-48% -$22.8K 0.01% 1090
2019
Q1 		$50K Buy
999
+503
+101% +$29.7K 0.02% 864
2018
Q4 		$29K Buy
+496
New +$32K 0.02% 924

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Quantamental Technologies's EBS Position: Q3 2022 in Review

Quantamental Technologies sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 7,291 shares — an estimated $226K sold.

Quantamental Technologies first reported a position in EBS in Q4 2018 and held it in 7 quarters. The position peaked at $316K in Q1 2022. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Quantamental Technologies reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 7,291 Emergent Biosolutions shares in Q3 2022, an estimated $226K.
  • Quantamental Technologies first reported a position in Emergent Biosolutions in Q4 2018 and held it in 7 quarters.
  • Quantamental Technologies's Emergent Biosolutions position peaked at $316K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.